Maximize Market Research, a leading Healthcare business consultancy and research firm has published a report on the “Anti Obesity Drugs Market”. The total market opportunity for Anti-Obesity Drugs Market was USD 2.22 Bn in 2023 and is expected to grow at a CAGR of 15.1 percent through the forecast period, reaching USD 5.95 Bn by 2030. As per the report, the global Anti-Obesity Drugs Market is expected to be dominated by the North American and Asia Pacific regions to grow at a significant growth rate through the forecast period.
Anti-Obesity Drugs Market Report Scope and Research Methodology
Market Size in 2023: USD 2.22 Billion
Market Size in 2030: USD 5.95 Billion
CAGR: 15.1 Percent
Forecast Period: 2024-2030
Base Year: 2023
Number of Pages: 215
No. of Tables: 136
No. of Charts and Figures: 191
Segment Covered: By mechanism of action,By Drug Type,By Distribution Channel
Regional Scope: North America, Europe, Asia Pacific, Middle East and Africa, South America
Report Coverage: Market Share, Size and Forecast by Revenue | 2023−2030, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, MMR Competition Matrix, Competitive Leadership Mapping, Global Key Players’ Market Ranking Analysis.
Get a free sample copy to fully comprehend the format of the report, which includes the table of contents and summary:https://www.maximizemarketresearch.com/request-sample/100768
Anti-Obesity Drugs Market Scope and Research Methodology
The Anti-Obesity Drugs Market analysis thoroughly examines the market structure and competitive landscape using a bottom-up approach to calculate the industry’s size and growth. Key findings include drivers of market growth at regional and global levels, barriers to future growth, and potential opportunities arising from technological advancements. Regional analysis is conducted to provide insights into market leaders, penetration, and demographic influences on the industry. The market is segmented into By mechanism of action ,By drug Types,By distribution Channel, allowing for a deeper understanding of target markets, and producers, and the development of tailored advertising campaigns. A competitive matrix is created to analyze the competition in the Anti Obesity Drugs Market, including both market leaders and new entrants. The report provides a summary of each company with key points on revenue, financial status, technology progress, recent changes, mergers, partnerships, collaborations, and marketing strategies.
Anti-Obesity Drugs Market Overview
The Anti-Obesity Drugs Market is expected to rise because of the rising cases of obesity and overweight among patients worldwide as a result of inactive lifestyles and bad eating habits. The World Health Organization (WHO) estimates that over 1.8 billion adults aged 18 and above were overweight in 2023.However Region wise North America dominated the Anti-Obesity Drugs Market . The Major factors accounting for the steep increase in global obesity are increased access to energy-dense food coupled with reduced physical activity. Sleep deprivation, circadian desynchronization, chronic stress and the use of anti-epileptic and psychotropic drugs propelled weight gain.
Anti-Obesity Drugs Market Dynamics
The anti-obesity drugs market is driven by rising case of obesity and lack of physical exercises As lifestyle and behavioural interventions provide moderate efficacy, obesity treatment strategies escalated by adding pharmacological and/or surgical interventions The pursuit of anti-obesity medications (AOMs) has been tremendously challenging for technical and societal reasons. Because certain drugs are recommended only for short-term use, due to addictive potential or emergence of tachyphylaxis (phentermine, amfepramone, cathin hydrochloride) Nonetheless, phentermine has not shown adverse cardiovascular outcomes in real-life studies and remains a commonly prescribed long-term AOM
Anti-Obesity Drugs Market Regional Insights
North America dominated the Anti-Obesity Drugs Market and is expected to grow with an increasing CAGR through the forecast period. As obesity rates rise among older adults and less physical activity However Asia Pacific Region is Expected to grow because due to rising population and lack of physical activity amongs people which leads to increase demand of Anti Obesity Drugs in this Region
Instant access is available by downloading your exclusive sample copy of the report right now!
Anti-Obesity Drugs Market Segmentation
By Mechanism Of Action :
- Peripherally Acting Drugs
- Centrally Acting Drugs
By Mechanism Of Action , Antiobesity drugs act through several potential mechanisms including increase energy expenditure, appetite suppression, inhibition of digestive enzymes, or interference in the absorption, at the level of the intestinal tract, of fat or sugar from food.
The majority of Anti Obesity Drugs act centrally, to reduce appetite and increase satiety, and secondarily, in the gastrointestinal tract to slow gastric emptying. All anti-obesity medications improve weight and metabolic parameters, with variable potency and effects depending on the specific drug.
By Drugs Type
- Prescription Drugs
- OTC Drugs
By Distribution Channel :
- Hospitals pharmacies
- Retail Pharmacies
- E- Commerce
Anti-Obesity Drugs Market Key Competitors include:
North America
- Icahn Enterprises
- Pfizer
- Orexigen Therapeutics
- Bristol-Myers Squibb
Europe
- Novo Nordisk
- Roche
- Norgine
- GSK
- Saniona
- AstraZeneca
- Hikma Pharmaceuticals
Asia Pacific
- Eisai
- Takeda Pharmaceutical Company
- Sanofi India
- Sun Pharmaceutical Industries
- Teijin Pharma
- Kowa
- Cipla
- Torrent Pharmaceuticals
- Zydus Lifesciences
- Glenmark Pharmaceuticals
Middle East & Africa
- Teva Pharmaceutical Industries
- Gulf Pharmaceutical Industries
- Saudi Pharmaceutical Industries & Medical Appliances
- The Jordanian Pharmaceutical Manufacturing Company
South America
- Eurofarma Laboratorios
- XXX
Key questions answered in the Anti-Obesity Drugs Market are:
- What is Obesity ?
- What is the current growth rate of theAnti Obesity Drugs Market?
- Who are the key players in the Global Anti Obesity Drugs Market?
- What are the growth prospects in developing countries for the Global Anti Obesity Drugs Market?
- Which segment is expected to witness the fastest growth and why in the Global Anti Obesity Market?
- What are the factors affecting growth in the Global Anti Obesity Market?
- Who held the largest market share in the Global Anti Obesity Market?
- What are the opportunities for the Global Anti Obesity Market?
- What are the strategies used by competitors in the Global Anti Obesity Market?
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2023)
- Past Pricing and price curve by region (2018 to 2023)
- Market Size, Share, Size & Forecast by Different Segments | 2023−2030
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
- Market Segmentation – A detailed analysis by Product, Sales Channel, Feature, and Age Group and Region
- Competitive Landscape – Profiles of selected key players by region in a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
Anti-Wrinkle Products Market – The Anti-Wrinkle Products Market size was valued at USD 12.11 Billion in 2023 and the total Anti-Wrinkle Products revenue is expected to grow at a CAGR of 6.4% from 2024 to 2030, reaching nearly USD 19.11 Billion by 2030.Anti-winkle products are formulated hygiene products that aim to reduce the development of wrinkles, fine lines, and indicators of aging on the skin, formulated with active ingredients.
Global Bispecific Antibodies Market– Global Bispecific Antibodies Market size was valued at USD 0.58 billion in 2023 and expected to reach USD 0.95 billion by 2030, at CAGR of 7.39%.Bispecific antibodies are an unusual type of antibody that may attach to two distinct targets simultaneously. Due to their special ability to interact with two separate cells or molecules, they are useful for a variety of therapeutic purposes. The market is growing as a result of the increased incidence of cancer and other diseases, the rising desire for personalized medicine, and the developments in bispecific antibody technology. The constant clinical trial carried out by several pharma companies is also expected to drive the growth of the market.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Media Contact
Company Name: MAXIMIZE MARKET RESEARCH PVT. LTD.
Contact Person: L Godage
Email: Send Email
Phone: +91 9607365656
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,
City: Pune
State: Maharashtra
Country: India
Website: https://www.maximizemarketresearch.com/market-report/global-anti-obesity-drugs-market/100768/